Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0L3TR
|
|||
Former ID |
DIB005743
|
|||
Drug Name |
Estetrol
|
|||
Synonyms |
Estetrol (oral, contraception/hormone deficiency/osteoporosis/cardiovascular disease/autoimmune disease/breast cancer/prostate cancer); Estetrol (oral, contraception/hormone deficiency/osteoporosis/cardiovascular disease/autoimmune disease/breast cancer/prostate cancer), Pantarhei; Estrogen receptor modulator (oral, contraception/hormone deficiency/autoimmune disease/breast cancer/prostate cancer/osteoporosis/cardiovascular disease), Pantarhei
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Autoimmune diabetes [ICD-11: 5A10] | Phase 2 | [1] | |
Company |
Pantarhei Bioscience BV
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H24O4
|
|||
Canonical SMILES |
CC12CCC3C(C1C(C(C2O)O)O)CCC4=C3C=CC(=C4)O
|
|||
InChI |
1S/C18H24O4/c1-18-7-6-12-11-5-3-10(19)8-9(11)2-4-13(12)14(18)15(20)16(21)17(18)22/h3,5,8,12-17,19-22H,2,4,6-7H2,1H3/t12-,13-,14-,15-,16-,17+,18+/m1/s1
|
|||
InChIKey |
AJIPIJNNOJSSQC-NYLIRDPKSA-N
|
|||
CAS Number |
CAS 15183-37-6
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:142773
|
References | Top | |||
---|---|---|---|---|
REF 1 | ClinicalTrials.gov (NCT00563472) Feasibility Study Into the Contraceptive Effect of Estetrol. U.S. National Institutes of Health. | |||
REF 2 | Clinical pipeline report, company report or official report of Pantarhei Bioscience. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.